India, March 18 -- Energy Fuels Inc. (EFR.TO) and The Chemours Company Tuesday have announced a strategic alliance to enhance domestic rare earth and critical mineral supply chains. The partnership l... Read More
India, March 18 -- Actinium Pharmaceuticals, Inc. (ATNM) Tuesday has launched a clinical program evaluating Actimab-A in combination with the PD-1 inhibitors pembrolizumab - KEYTRUDA and nivolumab OPD... Read More
India, March 18 -- Outset Medical, Inc. (OM) announced a one-for-fifteen reverse stock split of its common stock, effective March 20, 2025. Trading will continue under the ticker OM on Nasdaq with a ... Read More
India, March 18 -- Marriott International, Inc. (MAR) Tuesday has announced the launch of City Express by Marriott Duluth - GA, marking the brand's U.S. debut in the affordable midscale segment. Avai... Read More
India, March 18 -- Oracle (ORCL) Tuesday has announced the release of Java 24 - Oracle JDK 24, featuring thousands of improvements to enhance developer productivity, platform stability, security, and ... Read More
India, March 18 -- Phillips 66 (PSX) will present in a fireside chat at the Piper Sandler 25th Annual Energy Conference. The event is scheduled to begin at 1:50 PM ET on March 18, 2025. To access th... Read More
India, March 18 -- IHS Holding Limited (IHS) is trading at $4.2470, up 8.62 percent or $0.3370 during Tuesday's trading, after reporting a net income of $243.1 million for the fourth quarter, a signif... Read More
India, March 18 -- HUYA Inc. (HUYA) is trading at $3.8050, down 16.19 percent or $0.7350 during Tuesday's trading, after reporting a decline in total net revenues for the fourth quarter of 2024. Reven... Read More
India, March 18 -- Economic confidence from Germany and foreign trade data from the euro area are the top economic news due on Tuesday. At 4.00 am ET, the State Secretariat for Economic Affairs relea... Read More
India, March 18 -- Indaptus Therapeutics, Inc. (INDP) is trading at $0.8661, up 8.13 percent or $0.0651 during Tuesday's trading, after announcing the expansion of its Phase 1b/2 clinical trial of Dec... Read More